05:55 PM EST, 11/05/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Revenue declined 8% LFL, in line with guidance, while adjusted EBITDA fell 18% to $296M and adjusted EPS dropped 20% to $0.12. Prestige showed relative resilience with a 6% LFL decline versus Consumer Beauty's steeper 11% drop, though U.S. Prestige fragrance sell-out stabilized after lagging for several quarters. Management expects Q2 LFL sales at the favorable end of its -3% to -5% guidance range, with adjusted EBITDA still declining by low- to mid-teens. The company reaffirmed its full-year $1B adjusted EBITDA target and expects return to both LFL sales and EBITDA growth in 2H FY 26. Leverage increased to 3.7x from 3.5x despite improved free cash flow of $11.2M, with financial net debt of $3.8B highlighting ongoing deleveraging challenges. The active pursuit of Wella monetization remains critical for achieving investment-grade profile goals, while the strong innovation pipeline should support the anticipated 2H recovery.